These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6429674)

  • 21. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.
    Shaywitz BA; Pearson DA
    Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
    Chapman AG; Dürmuller N; Lees GJ; Meldrum BS
    Neurosci Lett; 1989 Dec; 107(1-3):256-60. PubMed ID: 2515501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.
    Reavill C; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Mar; 32(5):865-70. PubMed ID: 6301501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior.
    Levine TE; Erinoff L; Dregits DP; Seiden LS
    Pharmacol Biochem Behav; 1980 Feb; 12(2):281-5. PubMed ID: 7375490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of chronotropic responsiveness after systemic 6-hydroxydopamine treatment: studies in the pithed rat.
    Fluharty SJ; Vollmer RR; Meyers SA; McCann MJ; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):415-23. PubMed ID: 2890754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
    Sawynok J; Reid A
    J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal 6-hydroxydopamine potentiates clonidine's locomotor effects throughout maturation in the rat.
    Smythe JW; Pappas BA
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1075-8. PubMed ID: 3927324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats.
    Facchinetti F; Dall'Olio R; Ciani E; Sparapani M; Virgili M; Contestabile A
    Neuroscience; 1994 May; 60(2):343-53. PubMed ID: 7915409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH; Miller RJ; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenaline turnover in the tissues of uraemic rats.
    Ksiazek A; Solski J
    Int Urol Nephrol; 1990; 22(1):89-93. PubMed ID: 2116379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
    Martin-Iverson MT; Leclere JF; Fibiger HC
    Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):195-203. PubMed ID: 6817851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity.
    Kovàcs GL; Sarnyai Z; Barbarczi E; Szabó G; Telegdy G
    Neuropharmacology; 1990 Apr; 29(4):365-8. PubMed ID: 2160623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in striatal acetylcholine by picrotoxin in the rat: evidence for a gabergic-dopaminergic-cholinergic link.
    Ladinsky H; Consolo S; Bianchi S; Jori A
    Brain Res; 1976 May; 108(2):351-61. PubMed ID: 945112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic studies of the central action of zopiclone: effects on locomotor activity and brain monoamines in rats.
    Liu HJ; Sato K; Shih HC; Shibuya T; Kawamoto H; Kitagawa H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):121-8. PubMed ID: 2581904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional validation of projection topography in the nigrostriatal dopamine system.
    Redgrave P; Mitchell I
    Neuroscience; 1982 Apr; 7(4):885-94. PubMed ID: 6808415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain.
    Shaughnessy LW; Barone S; Mundy WR; Herr DW; Tilson HA
    Brain Res; 1994 Feb; 637(1-2):15-26. PubMed ID: 8180792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.